• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0030990882
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/10/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 80% stenosed target lesion was located in the moderately tortuous and mildly calcified circumflex artery.A 2.25 x 8mm synergy xd drug-eluting stent (des) was opened out of the package, but the shaft was visibly broken at proximal to the hub.Another 2.25 x 8mm synergy des was opened and advanced but it failed to cross the lesion.However, when the physician attempted to twist the stent, it did not look right, and upon removal from the sheath, the shaft was also broken at proximal to the stent balloon.The procedure was completed with a non-boston scientific device.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr: synergy xd mr us 2.25 x 8mm was returned for analysis.A visual and tactile inspection revealed no issues identified with the hypotube shaft.A visual, tactile and microscopic examination of the outer and inner lumen and mid-shaft section identified a break at the guidewire exchange port with the distal section not returned for analysis.The stent, balloon and tip were not returned for analysis.
 
Event or Problem Description
It was reported that shaft break occurred.The 80% stenosed target lesion was located in the moderately tortuous and mildly calcified circumflex artery.A 2.25 x 8mm synergy xd drug-eluting stent (des) was opened out of the package, but the shaft was visibly broken at proximal to the hub.Another 2.25 x 8mm synergy des was opened and advanced but it failed to cross the lesion.However, when the physician attempted to twist the stent, it did not look right, and upon removal from the sheath, the shaft was also broken at proximal to the stent balloon.The procedure was completed with a non-boston scientific device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19445844
Report Number2124215-2024-31749
Device Sequence Number8507603
Product Code NIQ
UDI-Device Identifier08714729980704
UDI-Public08714729980704
Combination Product (Y/N)Y
Initial Reporter StateLA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/23/2025
Device Lot Number0030990882
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/22/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/10/2024
Supplement Date Received by Manufacturer06/07/2024
Initial Report FDA Received Date06/03/2024
Supplement Report FDA Received Date06/21/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/24/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-